At Nextern, we excel in developing Class III active implantable leads and delivery systems. Our innovative solutions serve a variety of applications and offer comprehensive partnership support from start to finish. Read more about how we can bring your implantable leads to market: https://lnkd.in/geM7mk5n #Implantableleads #neurovascular #cardiovascular #MedicalDevices #Innovation #Healthcare #ImplantableTechnology #QualityEngineering #MedicalInnovation
Nextern’s Post
More Relevant Posts
-
AQUA Heart, Inc., an advanced MedTech startup that's leading the charge in medical innovation. Their state-of-the-art single-shot Pulmonary Vein Isolation therapy is poised to transform the landscape of atrial fibrillation treatment. It is faster, safer, and more easily applicable. With an unwavering commitment to excellence and a team of world-class experts, AQUA Heart is at the forefront of cardiovascular solutions, pushing boundaries and setting new standards in patient care. Atrial Fibrillation, a potentially life-threatening condition, often goes untreated in a majority of cases. AQUA Heart is on a mission to change that. Their groundbreaking high-energy, short-duration, single-shot Pulmonary Vein Isolation technology is making curative treatment more accessible on a global scale. Sophisticated investors can discover more and take action through this link: https://lnkd.in/dUXn2kqF #medtech #investmentopportunity #technology
To view or add a comment, sign in
-
The Global Fetal and Neonatal Care Equipment Market was valued at USD 8,623.1 million in 2023 and is expected to reach USD 13,847.9 million by 2031 while growing at a CAGR of 6.1% during the forecast period (2024-2031). Download a free sample: https://rb.gy/axsrj7 A few of the leading players operating in the market are Inspiration Healthcare, Medtronic, Philips, Dräger, Rocket Medical, Masimo, ATOM Medical USA, Vyaire Medical, and Arjo #fetalequipmentmarket #neonatalequipmentmarket #fetalequipmentmarketsize #fetalequipmentmarketshare #fetalequipmentmarketopportunity, #neonatalmarketsize #fetaldopplermarketsize #neonatalequipmentmarketgrowth #fetalandneonatalmarket
To view or add a comment, sign in
-
AQUA Heart, Inc. , an advanced MedTech startup that's leading the charge in medical innovation. Their state-of-the-art single-shot Pulmonary Vein Isolation therapy is poised to transform the landscape of atrial fibrillation treatment. It is faster, safer, and more easily applicable. With an unwavering commitment to excellence and a team of world-class experts, AQUA Heart is at the forefront of cardiovascular solutions, pushing boundaries and setting new standards in patient care. Atrial Fibrillation, a potentially life-threatening condition, often goes untreated in a majority of cases. AQUA Heart is on a mission to change that. Their groundbreaking high-energy, short-duration, single-shot Pulmonary Vein Isolation technology is making curative treatment more accessible on a global scale. Sophisticated investors can discover more and take action through this link: https://lnkd.in/eFJgfr33 #medical #cardiovascular #patientcare #opportunity
To view or add a comment, sign in
-
In recent news from Boston Scientific ! FDA approval for the POLARx Cryoablation System, a breakthrough for paroxysmal atrial fibrillation treatment. The POLARx FIT cryoablation balloon catheter, offering two sizes in a single catheter, revolutionizes electrophysiology. Addressing unmet needs, this innovation ensures procedural flexibility and individualized care. Kudos to Boston Scientific for advancing AF treatment and enhancing patient outcomes. Learn more on this https://lnkd.in/eukwD84W 🔔 Don't miss the opportunity to explore the future of healthcare! follow and share the Practical Patient Care page and also subscribe to our weekly newsletter🔔 #practicalpatientcare #ppc #bostonscientific #FDAApproval #HealthcareAdvancements #polarx
To view or add a comment, sign in
-
Please read the third instalment of Otsuka Medical Devices Co., Ltd.'s four-part series on innovation at OMD, introducing the group companies.
Discover Our Story #3: Global R&D We are excited to introduce our group companies and their specialized focus areas: - Recor Medical in the US, pioneering ultrasound renal denervation therapy - Veryan Medical in the UK and Ireland, leading advancements in peripheral vascular therapy - JIMRO in Japan, advancing cutting-edge medical devices used in cytapheresis therapy. United in our mission, we are dedicated to providing treatment alternatives to patients worldwide. Discover more at https://lnkd.in/g_dTqHZc #DiscoverOurStory #GlobalRandDNetwork #InnovationTogether
To view or add a comment, sign in
-
A new era in SCS technology is here! We celebrate those physicians who performed the first commercial implants of the Inceptiv™ spinal cord stimulator with closed-loop technology. Congratulations Dr. Georgios Matis, Cologne Univ. Hospital, Germany; Dr. Dirk Rasche, UKSH Lübeck, Germany; Prof. Paul Murphy, St. Vincent's Private Hospital, Ireland; Dr. Iris Smet and team, Vitaz Hospital, Belgium; Dr. Ash Gulve, James Cook Hospital, UK. This is a big milestone as we celebrate the use of the most advanced SCS system with a closed-loop feature that senses each person’s unique biological signals and adjusts stimulation moment to moment, as needed, to keep therapy in harmony with the motions of daily life†. Inceptiv™ is only approved in the EU and Japan. †Sensing signals may not be measurable in all cases. #neuromodulation #MedtronicPainInterventions #MedtronicSCS #Inceptiv #closedloopSCS #SpinalCordStimulation https://bit.ly/3Sw9qFz
To view or add a comment, sign in
-
Peripheral intravenous (IV) insertions are a common procedure in healthcare settings. However, locating suitable veins can be challenging, especially in obese or dehydrated patients. There is a solution to this problem– using infrared vein finders improves the efficiency and success rates of peripheral IV insertions. With near-infrared light technology, these devices can visualize the underlying vascular anatomy, allowing healthcare professionals to identify optimal veins for cannulation. The science behind this technology explores the potential benefits, including increased first-attempt success rates, reduced patient discomfort, and improved overall procedural efficiency. Medical professionals hope to optimize their peripheral IV insertion techniques using these new and innovative resources. THE ABRAHAMIC BUSINESS CIRCLE Tactical Management Nagel & Partners #Medicine #Technology #Innovation #Health
To view or add a comment, sign in
-
📣 Leveraging our advanced cardiovascular and endovascular technologies, we’ve created a unique approach to #spinalcordstimulation therapy: one that’s not just implanted, but connected to the needs of patients and providers. #BIOTRONIK pioneered the ability to monitor patients remotely. BIOTRONIK Neuro has built upon this technology to create Embrace One, a truly proactive patient-centric care ecosystem. It gives patients confidence in knowing that they have a trained expert who ensures that their #pain relief is optimized for the lifetime of therapy. Learn more about how we’re connected to what counts: https://ow.ly/AMjH50QVBnx #PainManagement #RemoteMonitoring #PatientCare
To view or add a comment, sign in
-
Introducing Inceptiv™ neurostimulator. The only SCS system to offer multiple waveforms flexibility which can be optimized with closed-loop technology †, allowing patients to maintain a consistent therapy during their daily activites. Learn more. #neuromodulation #MedtronicPainInterventions #MedtronicSCS #Inceptiv #closedloopSCS #SpinalCordStimulation #MeetInceptiv †Sensing signals may not be measureable in all cases. #MedtronicEmployee
Learn more about Inceptivᵀᴹ SCS
mvp.medtronic.com
To view or add a comment, sign in
17,906 followers